Long-term effects of GnRH agonists on fertility and behaviour.

This review aimed to summarize the present knowledge about the effects of GnRH agonist slow-release implants (GnRH A-SRI) on fertility and behaviour in male and female dogs and cats with special focus on deslorelin. Following an initial stimulation of gonadotropin and testosterone secretion possibly associated with an improved semen quality, GnRH A-SRI induce long-term depression of fertility in male dogs and cats with, however, a large individual variation in onset and duration of efficacy especially in cats. The GnRH A-SRI furthermore interfere with testosterone-dependent/affected behaviour; a significant positive effect in reducing sexual behaviour and libido, hypersexuality, intermale dominance and excessive territorial urine marking has been described. Rates of improvement of the respective behaviour are comparable to those after surgical castration, making GnRH A-SRI a valuable option to predict castration-related effects on behaviour and to identify animals where surgical castration will not be beneficial. No effect has been seen in reducing aggression towards humans indicating the need for behavioural therapy to control this problem. Effects on spermatogenesis, steroidogenesis and behaviour have by now been shown to be fully reversible. Knowledge in females is more limited, and particularly, the initial induction of a possibly fertile oestrus and individual variation in duration of efficacy remain problems in bitches and queens treated for suppression of fertility. However, long-term suppression of oestrous cycle and fertility seems to be possible with induced effects shown to be reversible including restoration of normal fertility after the end of efficacy/GNRH A-SRI removal.

[1]  J. Thuróczy,et al.  Effect of deslorelin on testicular function, serum dihydrotestosterone and oestradiol concentrations during and after suppression of sexual activity in tom cats , 2017, Journal of feline medicine and surgery.

[2]  S. Romagnoli,et al.  Semen quality and interval to sterility in tom cats treated with a 9.4 mg deslorelin implant , 2017, Journal of feline medicine and surgery.

[3]  C. Béata,et al.  La desloréline (Suprelorin®) pourrait-elle être utilisée dans certaines affections comportementales : une étude préliminaire , 2016 .

[4]  M. Khalid,et al.  GnRH-agonist implantation of prepubertal male cats affects their reproductive performance and testicular LH receptor and FSH receptor expression. , 2016, Theriogenology.

[5]  R. Payan-Carreira,et al.  Fertility in Adult Bitches Previously Treated with a 4.7 mg Subcutaneous Deslorelin Implant. , 2015, Reproduction in domestic animals = Zuchthygiene.

[6]  D. Zambelli,et al.  First deliveries after estrus induction using deslorelin and endoscopic transcervical insemination in the queen. , 2015, Theriogenology.

[7]  P. Fernández,et al.  Histologic effect of a postnatal slow-release GnRH agonist on feline gonads. , 2015, Theriogenology.

[8]  P. Čížek,et al.  Azoospermia with variable testicular histology after 7 months of treatment with a deslorelin implant in toms. , 2015, Theriogenology.

[9]  S. Kaya,et al.  Clinical use of deslorelin implants for the long-term contraception in prepubertal bitches: effects on epiphyseal closure, body development, and time to puberty. , 2015, Theriogenology.

[10]  M. Merlo,et al.  Effect of GnRH analogs in postnatal domestic cats. , 2014, Theriogenology.

[11]  A. Wehrend,et al.  Suppression of fertility in adult cats. , 2014, Reproduction in domestic animals = Zuchthygiene.

[12]  N. Santos,et al.  Suppression of fertility in adult dogs. , 2014, Reproduction in domestic animals = Zuchthygiene.

[13]  S. Schlatt,et al.  Regulation of spermatogenesis: an evolutionary biologist's perspective. , 2014, Seminars in cell & developmental biology.

[14]  A. Wehrend,et al.  Reversibility of germinative and endocrine testicular function after long-term contraception with a GnRH-agonist implant in the tom-a follow-up study. , 2014, Theriogenology.

[15]  M. Veronesi,et al.  Effectiveness of deslorelin acetate subcutaneous implantation in a domestic queen with after-spaying urinary incontinence , 2014, Journal of feline medicine and surgery.

[16]  K. Failing,et al.  Status of the down-regulated canine testis using two different GNRH agonist implants in comparison with the juvenile testis. , 2013, Reproduction.

[17]  A. Troisi,et al.  Clinical efficacy of the GnRH agonist (deslorelin) in dogs affected by benign prostatic hyperplasia and evaluation of prostatic blood flow by Doppler ultrasound. , 2013, Reproduction in domestic animals = Zuchthygiene.

[18]  A. Wehrend,et al.  Basal testosterone concentrations after the application of a slow-release GnRH agonist implant are associated with a loss of response to buserelin, a short-term GnRH agonist, in the tom cat. , 2013, Theriogenology.

[19]  A. Wehrend,et al.  Treatment with Suprelorin in a pregnant cat , 2013, Journal of feline medicine and surgery.

[20]  A. Wehrend,et al.  Treatment of queens in estrus and after estrus with a GnRH-agonist implant containing 4.7 mg deslorelin; hormonal response, duration of efficacy, and reversibility. , 2013, Theriogenology.

[21]  A. Wehrend,et al.  The use of Suprelorin® for estrus suppression in the bitch , 2013 .

[22]  C. Barbeito,et al.  Long-term-release GnRH agonists postpone puberty in domestic cats. , 2012, Reproduction in domestic animals = Zuchthygiene.

[23]  K. Reynaud,et al.  Results of GnRH agonist implants in oestrous induction and oestrous suppression in bitches and queens. , 2012, Reproduction in domestic animals = Zuchthygiene.

[24]  T. Trigg,et al.  Delay of puberty and reproductive performance in male dogs following the implantation of 4.7 and 9.4 mg GnRH-agonist deslorelin at an early pre-pubertal age. , 2012, Reproduction in domestic animals = Zuchthygiene.

[25]  S. Romagnoli,et al.  Semen quality and onset of sterility following administration of a 4.7-mg deslorelin implant in adult male dogs. , 2012, Reproduction in domestic animals = Zuchthygiene.

[26]  K. Failing,et al.  Restart of steroidogenesis in dogs during recrudescence of testicular function following downregulation with a GnRH-agonist implant , 2012, Cell and Tissue Research.

[27]  E. Trevisol,et al.  Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens. , 2012, Theriogenology.

[28]  P. Čížek,et al.  Reversible suppression of sexual activity in tomcats with deslorelin implant. , 2012, Theriogenology.

[29]  B. Hoffmann,et al.  Development of semen quality following reversible downregulation of testicular function in male dogs with a GnRH agonist implant. , 2012, Reproduction in domestic animals = Zuchthygiene.

[30]  C. Asa,et al.  Predominant Suppression of Follicle‐Stimulating Hormone β‐Immunoreactivity after Long‐Term Treatment of Intact and Castrate Adult Male Rats with the Gonadotrophin‐Releasing Hormone Agonist Deslorelin , 2012, Journal of neuroendocrinology.

[31]  V. Olgac,et al.  Effects of the GnRH analogue deslorelin implants on reproduction in female domestic cats. , 2012, Theriogenology.

[32]  I. Reichler,et al.  Der Einsatz von Deslorelinazetat (Suprelorin®) in der Kleintiermedizin , 2012 .

[33]  C. Navarro,et al.  Induction of fertile oestrus in the bitch using Deslorelin, a GnRH agonist. , 2011, Theriogenology.

[34]  A. Fontbonne,et al.  Clinical use of GnRH agonists in canine and feline species. , 2011, Reproduction in domestic animals = Zuchthygiene.

[35]  A. Wehrend,et al.  Clinical efficacy of a GnRH-agonist implant containing 4.7 mg deslorelin, Suprelorin, regarding suppression of reproductive function in tomcats. Sandra.Pesch@vetmed.uni-giessen.de. , 2011, Theriogenology.

[36]  W. Heuwieser,et al.  Follicular cysts and prolonged oestrus in a female dog after administration of a deslorelin implant , 2011, New Zealand veterinary journal.

[37]  M. Driancourt,et al.  Evaluation of the clinical efficacy of Gonazon implants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog. , 2010, Theriogenology.

[38]  G. Martin,et al.  Dose-response studies for pituitary and testicular function in male dogs treated with the GnRH superagonist, deslorelin. , 2009, Reproduction in domestic animals = Zuchthygiene.

[39]  G. Martin,et al.  Morphological study of the effects of the GnRH superagonist deslorelin on the canine testis and prostate gland. , 2009, Reproduction in domestic animals = Zuchthygiene.

[40]  B. Hoffmann,et al.  Recrudescence of spermatogenesis in the dog following downregulation using a slow release GnRH agonist implant. , 2009, Reproduction in domestic animals = Zuchthygiene.

[41]  M. Driancourt,et al.  Controlled delivery of a GnRH agonist by a silastic implant (Gonazon) results in long-term contraception in queens. , 2009, Reproduction in domestic animals = Zuchthygiene.

[42]  M. Driancourt,et al.  Reversible downregulation of endocrine and germinative testicular function (hormonal castration) in the dog with the GnRH-agonist azagly-nafarelin as a removable implant "Gonazon"; a preclinical trial. , 2009, Theriogenology.

[43]  H. Kooistra,et al.  Physiology of the canine anoestrus and methods for manipulation of its length. , 2008, Reproduction in domestic animals = Zuchthygiene.

[44]  G. Martin,et al.  Pituitary and testicular endocrine responses to exogenous gonadotrophin-releasing hormone (GnRH) and luteinising hormone in male dogs treated with GnRH agonist implants. , 2007, Reproduction, fertility, and development.

[45]  M. Roos,et al.  Urodynamic parameters and plasma LH/FSH in spayed Beagle bitches before and 8 weeks after GnRH depot analogue treatment. , 2006, Theriogenology.

[46]  M. Driancourt,et al.  Treatment with a subcutaneous GnRH agonist containing controlled release device reversibly prevents puberty in bitches. , 2006, Theriogenology.

[47]  T. Trigg,et al.  A review of advances in the use of the GnRH agonist deslorelin in control of reproduction. , 2006, Theriogenology.

[48]  P. Wright,et al.  The influence of exogenous progestin on the occurrence of proestrous or estrous signs, plasma concentrations of luteinizing hormone and estradiol in deslorelin (GnRH agonist) treated anestrous bitches. , 2006, Theriogenology.

[49]  T. Nett,et al.  Pituitary gonadotropin-releasing hormone (GnRH) receptor: structure, distribution and regulation of expression. , 2005, Animal reproduction science.

[50]  R. Braun,et al.  Hormonal regulation of spermatogenesis. , 2004, International journal of andrology.

[51]  G. Martin,et al.  Use of a new drug delivery formulation of the gonadotrophin-releasing hormone analogue Deslorelin for reversible long-term contraception in male dogs. , 2003, Reproduction, fertility, and development.

[52]  G. Martin,et al.  Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive function in male and female domestic dogs. , 2001, Journal of reproduction and fertility. Supplement.

[53]  C. Asa,et al.  Efficacy of the GnRH analogue deslorelin for suppression of oestrous cycles in cats. , 2001, Journal of reproduction and fertility. Supplement.